症状科学模型在2型糖尿病患者症状管理中的应用进展

doi:10.3761/j.issn.0254-1769.2026.09.019

中华护理杂志 ›› 2026, Vol. 61 ›› Issue (9): 1284-1290.DOI: 10.3761/j.issn.0254-1769.2026.09.019

症状科学模型在2型糖尿病患者症状管理中的应用进展

张诗阳¹(), 刘荞瑀¹, 林小灵¹, 艾星星¹, 陈慈端¹, 黄洁微²^,^*()

¹ 暨南大学护理学院广州市 510632
² 暨南大学附属第一医院护理部广州市 510630

收稿日期:2025-08-26 出版日期:2026-05-10 发布日期:2026-04-30
*通讯作者: 黄洁微，E-mail：dmapn@126.com
作者简介:张诗阳：女，本科（硕士在读），护士，E-mail：2513038193@qq.com
第一联系人：作者贡献声明
张诗阳：选题设计、文献检索、文献整理与分析、核心概念确定、论文撰写与修改；刘荞瑀、林小灵、艾星星：文献整理与分析、论文修改；陈慈端：文献整理与分析；黄洁微：研究指导、论文审阅和修改
基金资助:
广东省数字孪生重点实验室基金项目(2022B1212010004)

Application progress of the symptom science model in symptom management of patients with type 2 diabetes mellitus

ZHANG Shiyang¹(), LIU Qiaoyu¹, LIN Xiaoling¹, AI Xingxing¹, CHEN Ciduan¹, HUANG Jiewei²^,^*()

¹ School of Nursing， Jinan University， Guangzhou 510632， China
² Nursing Department， the First Affiliated Hospital of Jinan University， Guangzhou 510630， China

Received:2025-08-26 Online:2026-05-10 Published:2026-04-30
* Corresponding author: HUANG Jiewei，E-mail：dmapn@126.com
Funding program:
Digital Twin Key Laboratory of Guangdong Province Fund Project(2022B1212010004)

摘要/Abstract

摘要：

症状科学模型作为系统化症状管理框架，可基于症状的生物学机制制订精准的护理干预方案，为2型糖尿病患者症状管理提供个性化护理支持。该文对症状科学模型的概念及发展历程、核心要素、在2型糖尿病患者症状管理中的应用进行综述，并提出与护理相关的建议，以期为2型糖尿病患者症状的科学管理提供参考。

关键词: 症状科学模型, 2型糖尿病, 症状管理, 精准护理, 综述

Abstract:

The Symptom Science Model serves as a systematic framework for symptom management，enabling the development of precise nursing interventions based on the biological mechanisms underlying symptoms，providing personalized nursing support for symptom management of patients with type 2 diabetes. This article reviews the concept，core elements，and application of the Symptom Science Model in symptom management for patients with type 2 diabetes，and proposes nursing-related recommendations to provide a reference for the scientific management of symptoms in these patients.

Key words: Symptom Science Model, Type 2 Diabetes Mellitus, Symptom Management, Precision Nursing, Review

张诗阳, 刘荞瑀, 林小灵, 艾星星, 陈慈端, 黄洁微. 症状科学模型在2型糖尿病患者症状管理中的应用进展[J]. 中华护理杂志, 2026, 61(9): 1284-1290.

ZHANG Shiyang, LIU Qiaoyu, LIN Xiaoling, AI Xingxing, CHEN Ciduan, HUANG Jiewei. Application progress of the symptom science model in symptom management of patients with type 2 diabetes mellitus[J]. Chinese Journal of Nursing, 2026, 61(9): 1284-1290.

参考文献 41

[1]	Genitsaridi I, Salpea P, Salim A, et al. 11th edition of the IDF Diabetes Atlas:global,regional,and national diabetes prevale-nce estimates for 2024 and projections for 2050[J]. Lancet Dia-betes Endocrinol, 2026, 14(2):149-156.
[2]	American Diabetes Association Professional Practice Committee 2. diagnosis and classification of diabetes:standards of care in diabetes-2024[J]. Diabetes Care, 2024, 47(Suppl 1):S20-S42.
[3]	GBD 2021 Diabetes Collaborators. Global,regional,and national burden of diabetes from 1990 to 2021,with projections of prevalence to 2050:a systematic analysis for the Global Bur-den of Disease Study 2021[J]. Lancet, 2023, 402(10397):203-234.
[4]	García AA, Bose E, Zuñiga JA, et al. Mexican Americans’ dia-betes symptom prevalence,burden,and clusters[J]. Appl Nurs Res, 2019, 46:37-42.
[5]	Cashion AK, Grady PA. The National Institutes of Health/Natio-nal Institutes of Nursing Research intramural research program and the development of the National Institutes of Health Sym-ptom Science Model[J]. Nurs Outlook, 2015, 63(4):484-487.
[6]	杨珍娇, 崔妙玲, 张小芳, 等. 慢性阻塞性肺疾病病人症状群及其与炎症因子水平的相关性[J]. 护理研究, 2021, 35(7):1134-1139.
	Yang ZJ, Cui ML, Zhang XF, et al. Symptom clusters of patients with chronic obstructive pulmonary disease and its correlation with the levels of inflammatory biomarkers[J]. Chin Nurs Res, 2021, 35(7):1134-1139.
[7]	梁轶岚, 姜伟, 何小爽, 等. 症状科学模型在慢性肾脏疾病患者中的研究进展及护理启示[J]. 中华护理杂志, 2025, 60(5):624-629.
	Liang YL, Jiang W, He XS, et al. Research progress of symp-tom science model in chronic kidney disease[J]. Chin J Nurs, 2025, 60(5):624-629.
[8]	Hickey KT, Bakken S, Byrne MW, et al. Precision health:ad-vancing symptom and self-management science[J]. Nurs Out-look, 2019, 67(4):462-475.
[9]	Kurnat-Thoma EL, Graves LY, Billones RR. A concept develop-ment for the symptom science model 2.0[J]. Nurs Res, 2022, 71(6):E48-E60.
[10]	Zhang JL, Zhang ZY, Zhang KQ, et al. Early detection of type 2 diabetes risk:limitations of current diagnostic criteria[J]. Front Endocrinol, 2023, 14:1260623.
[11]	Li HJ, Ji MH, Scott P, et al. The effect of symptom clusters on quality of life among patients with type 2 diabetes[J]. Diabetes Educ, 2019, 45(3):287-294.
[12]	张慧慧. 2型糖尿病患者症状群及相关变量的结构关系模型构建[D]. 广州: 广州中医药大学, 2022.
	Zhang HH. Construction of a structural relationship model of symptom clusters and related variables in patients with type 2 diabetes mellitus[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2022.
[13]	Liu YQ, Li SB, Li YM, et al. Exploring core and bridge symp-toms among people with type 2 diabetes mellitus in China:a network analysis[J]. J Clin Nurs, 2025.
[14]	谭婷婷, 王偲景, 杨涵, 等. 2型糖尿病患者症状网络及影响因素研究[J]. 中华现代护理杂志, 2025(15):2046-2052.
	Tan TT, Wang CJ, Yang H, et al. Study on symptom network and influencing factors of patients with type 2 diabetes mellitus[J]. Chin J Mod Nurs, 2025, 31(15):2046-2052.
[15]	Jones PJ, Ma RF, McNally RJ. Bridge centrality:a network approach to understanding comorbidity[J]. Multivariate Behav Res, 2021, 56(2):353-367.
[16]	Kusnanto K, Arifin H, Pradipta RO, et al. Resilience-based is-lamic program as a promising intervention on diabetes fati-gue and health-related quality of life[J]. PLoS One, 2022, 17(9):e0273675.
[17]	中华医学会心身医学分会心身内分泌协作学组, 中华预防医学会糖尿病预防与控制专业委员会. 糖尿病共患抑郁诊疗中国专家共识[J]. 中国全科医学, 2026, 29(3):273-292.
	Psychosomatic Endocrinology Collaboration Group of Psycho-somatic Medicine Branch of Chinese Medical Association, Diabetes Prevention and Control Committee of Chinese Pre-ventive Medicine Association. Chinese expert consensus on the diagnosis and treatment of diabetes comorbid with de-pression[J]. Chin Gen Pract, 2026, 29(3):273-292.
[18]	中国微循环学会糖尿病与微循环专业委员会, 中华医学会内分泌学分会基层内分泌代谢病学组. 基层糖尿病微血管疾病筛查与防治专家共识(2024)[J]. 中国全科医学, 2024, 27(32):3969-3986.
	Diabetes and Microcirculation Professional Committee of Chinese Society of Microcirculation; Primary Endocrine and Metabolic Diseases Group of the Chinese Society of Endoc-rinology. Expert consensus on screening and prevention of diabetic microvascular disease for primary care(2024)[J]. Chin Gen Pract, 2024, 27(32):3969-3986.
[19]	Williams R, Karuranga S, Malanda B, et al. Global and regio-nal estimates and projections of diabetes-related health expen-diture:results from the International Diabetes Federation Dia-betes Atlas,9th edition[J]. Diabetes Res Clin Pract, 2020, 162:108072.
[20]	Tang SS, An XD, Sun WJ, et al. Parallelism and non-paralle-lism in diabetic nephropathy and diabetic retinopathy[J]. Front Endocrinol, 2024, 15:1336123.
[21]	Duan DF, Liu M, Ma DY, et al. Exploring symptom clusters in chinese patients with ciabetic kidney disease:a network ana-lysis[J]. Int J Gen Med, 2024, 17:871-884.
[22]	Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale:an instrument for the evaluation of symptom prevalence,characteristics and distress[J]. Eur J Cancer, 1994, 30A(9):1326-1336.
[23]	Cheng KKF, Wong EMC, Ling WM, et al. Measuring the sym-ptom experience of Chinese cancer patients:a validation of the Chinese version of the Memorial Symptom Assessment Scale[J]. J Pain Symptom Manage, 2009, 37(1):44-57.
[24]	Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System(ESAS):a simple method for the assess-ment of palliative care patients[J]. J Palliat Care, 1991, 7(2):6-9.
[25]	Dong YX, Chen H, Zheng YY, et al. Psychometric validation of the Edmonton Symptom Assessment System in Chinese patients[J]. J Pain Symptom Manage, 2015, 50(5):712-717.
[26]	Suarez GA, Opfer-Gehrking TL, Offord KP, et al. The Autono-mic Symptom Profile:a new instrument to assess autonomic symptoms[J]. Neurology, 1999, 52(3):523-528.
[27]	Greco C, Di Gennaro F, D’Amato C, et al. Validation of the Composite Autonomic Symptom Score 31(COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes[J]. Diabet Med, 2017, 34(6):834-838.
[28]	Zhang ZY, Ma YJ, Fu LJ, et al. Combination of Composite Autonomic Symptom Score 31 and heart rate variability for dia-gnosis of cardiovascular autonomic neuropathy in people with type 2 diabetes[J]. J Diabetes Res, 2020, 2020(1):5316769.
[29]	Feldman EL, Stevens MJ, Thomas PK, et al. A practical twostep quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy[J]. Diabetes Care, 1994, 17(11):1281-1289.
[30]	张红梅, 刘义珍, 卢金玉. 密歇根神经筛查量表对糖尿病神经病变筛查的适用性评价[J]. 中国卫生统计, 2021, 38(2):247-249.
	Zhang HM, Liu YZ, Lu JY. Applicability evaluation of Michi-gan Neuroscreening Scale for diabetic neuropathy screening[J]. Chin J Health Stat, 2021, 38(2):247-249.
[31]	Arbuckle RA, Humphrey L, Vardeva K, et al. Psychometric eva-luation of the Diabetes Symptom Checklist-Revised(DSC-R):a measure of symptom distress[J]. Value Health, 2009, 12(8):1168-1175.
[32]	罗倩. 2型糖尿病患者症状负担评估量表的汉化修订及应用研究[D]. 南昌: 南昌大学, 2023.
	Luo Q. Chinese revision and application study of Symptom Burden Assessment Scale for patients with type 2 diabetes mellitus[D]. Nanchang: Nanchang University, 2023.
[33]	Herder C, Zhu AN, Schmitt A, et al. Biomarkers of inflamma-tion and improvement in depressive symptoms in type 1 and type 2 diabetes:differential associations with depressive sym-ptom clusters[J]. Diabetologia, 2025, 68(9):2057-2068.
[34]	Deng RJ, Zhu SH, Fan B, et al. Exploring the correlations bet-ween six serological inflammatory markers and different stages of type 2 diabetic retinopathy[J]. Sci Rep, 2025, 15(1):1567.
[35]	Xhardo K, Xhardo E, Bratu M, et al. The impact of biodex balance on improving coordination and static balance in patients with diabetic peripheral neuropathy[J]. Life(Basel), 2025, 15(7):1030.
[36]	胡哲, 雷丹丹, 赵益, 等. 基于健康行为改变整合理论的护理干预对糖尿病视网膜病变患者的影响[J]. 中华护理杂志, 2024, 59(3):300-307.
	Hu Z, Lei DD, Zhao Y, et al. The effect of nursing inter-vention based on the integrated theory of health behavior change on the health behavior of patients with diabetes retinopathy[J]. Chin J Nurs, 2024, 59(3):300-307.
[37]	Abbas Q, Latif S, Ayaz Habib H, et al. Cognitive behavior the-rapy for diabetes distress,depression,health anxiety,quality of life and treatment adherence among patients with type-Ⅱ diabetes mellitus:a randomized control trial[J]. BMC Psychiatry, 2023, 23(1):86.
[38]	Nahum-Shani I, Smith SN, Spring BJ, et al. Just-in-time adap-tive interventions(JITAIs) in mobile health:key components and design principles for ongoing health behavior support[J]. Ann Behav Med, 2018, 52(6):446-462.
[39]	王晴, 黄晓婷, 唐四元, 等. 即时适配干预在护理领域中的应用进展[J]. 中华护理杂志, 2024, 59(4):490-495.
	Wang Q, Huang XT, Tang SY, et al. The application progress of just-in-time adaptive intervention in nursing[J]. Chin J Nurs, 2024, 59(4):490-495.
[40]	Wang LY, Miller L. Assessment and disruption of ruminative episodes to enhance mobile cognitive behavioral therapy just-in-time adaptive interventions in clinical depression:pilot ran-domized controlled trial[J]. JMIR Form Res, 2023, 7:e37270.
[41]	Hermanns N, Ehrmann D, Kulzer B, et al. Somatic and mental symptoms associated with dysglycaemia,diabetes-related com-plications and mental conditions in people with diabetes:assessments in daily life using continuous glucose monitoring and ecological momentary assessment[J]. Diabetes Obes Metab, 2025, 27(1):61-70.

症状科学模型在2型糖尿病患者症状管理中的应用进展

Application progress of the symptom science model in symptom management of patients with type 2 diabetes mellitus

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 41

相关文章 15

编辑推荐

Metrics

[1]	蔡卫新, 孙卫格, 张冉, 陈玮琪, 王毓盈, 王伊龙. 肌萎缩侧索硬化患者支持性照护需求的研究进展[J]. 中华护理杂志, 2026, 61(9): 1277-1283.
[2]	李秋桦, 傅桂芬, 蒋建华, 尹丹, 左静, 刘艳群. 可穿戴设备在炎症性肠病患者动态监测与管理中应用的范围综述[J]. 中华护理杂志, 2026, 61(8): 1132-1140.
[3]	熊丽莎, 袁越, 王思雪, 王云翠. 实施性研究视角下认知障碍患者干预方案保真度的研究进展[J]. 中华护理杂志, 2026, 61(8): 1141-1147.
[4]	李琰, 许翠萍. 数字生物标志物在癌症患者中的应用进展及护理启示[J]. 中华护理杂志, 2026, 61(8): 1148-1152.
[5]	史金瑞, 占婷婷, 郝文杰, 屠文洁, 朱艺航, 张杏杏. 肝豆状核变性患者的症状网络分析及护理启示[J]. 中华护理杂志, 2026, 61(7): 956-963.
[6]	曾佳琳, 符冰, 杨泠韵, 江庆华. 头颈癌患者自我报告结局评估工具的评价及护理启示[J]. 中华护理杂志, 2026, 61(7): 986-994.
[7]	王秀丽, 代春豪, 许梓婷, 李昊远, 冷敏敏, 张海博, 李晴, 杨丽娟. 运动干预在老年肌少性肥胖患者中应用的范围综述[J]. 中华护理杂志, 2026, 61(7): 995-1001.
[8]	贺敬婷, 应燕萍, 陆秋芳, 赵慧函, 刘丽颖, 马含章, 张程. 多模态数据在护理领域中应用的范围综述[J]. 中华护理杂志, 2026, 61(7): 1002-1008.
[9]	武玲, 吴波, 陈红, 古晨茜, 刘洋, 张春谨, 陈梦琪, 章青. 基于机器学习算法的成人术中低体温预测模型的范围综述[J]. 中华护理杂志, 2026, 61(6): 844-851.
[10]	郭晓贝, 王颖, 郭月, 崔梦影, 鲁志卉, 黄子菁. 方步运动在老年人运动认知风险综合征预防中的应用进展[J]. 中华护理杂志, 2026, 61(6): 852-857.
[11]	陈静, 王君君, 魏晓琼, 何欢, 孙秋怡, 唐莹, 韩莹, 何华云. 运动干预在幼年特发性关节炎患儿中应用的范围综述[J]. 中华护理杂志, 2026, 61(6): 858-864.
[12]	温佳, 郭慧芳, 郭晶晶, 田云霞, 杨玥, 刘波. 维持性血液透析患者社会疏离感的范围综述[J]. 中华护理杂志, 2026, 61(5): 605-611.
[13]	旷婉, 祝敏, 胡露红. 简短的正念干预在围手术期患者中应用的范围综述[J]. 中华护理杂志, 2026, 61(5): 707-714.
[14]	陈玲, 宋秀琪, 任伟, 余丽华, 全红梅, 杨亚妮, 蔡文智. 美国家庭开业护士的发展现状及启示[J]. 中华护理杂志, 2026, 61(5): 715-720.
[15]	陈丹露, 陈茹, 单亚维, 施春香, 沈中鸣. 远程医疗技术在全膝关节置换患者术后运动康复中应用的范围综述[J]. 中华护理杂志, 2026, 61(4): 467-474.